Remove 2024 Remove Pharmacogenetics Remove Trials
article thumbnail

Inside The Altascientist: Understanding Drug Interaction Factors for Safer, More Effective Therapies

Alta Sciences

According to the FDAs 2024 guidance titled M12 Drug Interaction Studies , clinically significant DDIs between investigational and other drugs should be addressed at various stages of drug development. The FDA, 2024 FDA guidance M12 Drug Interaction Studies , pg.